Hämostasestörungen in Geburtshilfe und Frauenheilkunde

L. Heilmann

doi:10.1055/s-0037-1619636

Hämostaseologie, Table of Contents

Hamostaseologie 2004; 24(04): 252-260
DOI: 10.1055/s-0037-1619636

Original Article

Schattauer GmbH

Hämostasestörungen in Geburtshilfe und Frauenheilkunde

Disorders of haemostasis in obstetrics and gynaecology

L. Heilmann

Abstract

Zusammenfassung

Es wird ein Überblick gegeben über die klinisch wichtigsten Hämostasestörungen in Geburtshilfe und Frauenheilkunde aus gynäkologischer und geburtshilflicher Sicht.

Summary

A survey is given on the clinical important haemostatic facts and diseases in gynaecology and obstetrics from the viewpoint of the gynecologist and obstetrician.

Schlüsselwörter

Thromboembolien - Thrombophilie - Gynäkologie - Geburtshilfe

Keywords

Thromboembolism - thrombophilia - gynaecology - obstetrics

Full Text

References

Literatur
1 Ajzenberg N, Dreyfus M, Kaplan C. et al. Pregnancy-associated thrombocytopenia revisited: Assessment and follow-up of 50 cases. Blood 1998; 92: 4573-80.
2 Aledort LM, Green D, Teitel JM. Unexpected bleeding disorders. Hematology 2001; 306-21.
3 Hague WM, Norten RH, Gallus AS. et al. Anticoagulation in pregnancy and the puerperium. Med J 2001; 175: 258263
4 Bhattacharyya B. Platelet disorders in pregnancy. In: Gleicher N. Medical therapy in pregnancy. Appleton & Lange; 1998
5 Boyer-Neumann C, Dreyfus M, Wolf M. et al. Multitherapeutic approach to manage delivery in an alloimmunized patient with type 3 von Willebrand disease. J Thromb Haemost 2003; 1: 190-2.
6 Breddin HK. Angeborene Thrombozytopathien. Hämostaseologie 1985; 5: 17-31.
7 Brill-Edwards P, Ginsberg J, Gent M. Safety of withholding antepartum heparine in women with a previous episode of venous thromboembolism. N Engl J Med 2000; 343: 1439-44.
8 Burrows RF, Hunter DJS, Andrew M. et al. A prospective study investigating the mechanism of thrombocytopenia in preeclampsia. Obstet Gynecol 1987; 70: 334-8.
9 Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993; 329: 1463-6.
10 Burrows RF, Kelton JG. Platelets and pregnancy. Current Obstet Med 1993; 2: 83-106.
11 Burrows RF, Kelton JG. Thrombocytopenia at delivery: A prospective survey of 6715 deliveries. Am J Obstet Gynecol 1990; 162: 731-4.
12 Burrows RF. Thrombocytopenia in the hypertensive disorders of pregnancy. Clin Exper Hyper Pregnancy 1990; B9: 199-209.
13 Castamann G, Federici AB, Rodeghiero F. et al. Von Willebrand’s disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. Haematologica 2003; 88: 94-108.
14 Chan WS, Ray JG. Low molecular weight heparin use during pregnancy: Issues of safety and practicality. Obstet Gynecol Survey 1999; 54: 649-654
15 Chon BH. Danaparoid for the treatment of heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia. New York, Basel: Marcel Dekker; 2000
16 Claessens EA, Cowell CA. Acute adolescent menorrhagia. Am J Obstet Gynecol 1981; 139: 277-80.
17 Cook RL, Miller RC, Katz VL. et al. Immune thrombocytopenic purpura in pregnancy: A reappraisal of management. Obstet Gynecol 1991; 78: 578-82.
18 De Groot PG. The role of von Willebrand factor in platelet function. Sem Thromb Haemost 2002; 28: 133-8.
19 Diagnosis and treatment of idiopathic thrombocytopenic purpura: Recommendations of the American Society of Hematology. Ann Int Med 1997; 126: 319-26.
20 Economides DL, Kadir RA, CA Lee CA. Inherited bleeding disorders in obstetrics and gynaecology. Brit J Obstet Gynaecol 1999; 106: 5-13.
21 Elliott MA, Nichols WL. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Mayo Clin Proc 2001; 76: 1154-62.
22 Fausett MB, Vogtlander M, Lee RM. et al. Heparin-induced thrombocytopenia is rare in pregnancy. Am J Obstet Gynecol 2001; 185: 148-52.
23 Fay RA, Hughes AO, Farron NT. Platelets in pregnancy: Hyperdestruction in pregnancy. Obstet Gynecol 1983; 61: 238-40.
24 Finazzi G. The Italian registry of antiphospholipid antibodies. Haematologica 1997; 82: 101-5.
25 Fischer T, Wildt L. Glukokortikoide und HELLP-Syndrom. Gynäkologe 1999; 32: 783-90.
26 Galli M, Finazzi G, Barbui T. Thrombozytopenia in the antiphospholipid syndrome. Br J Haematol 1996; 93: 1-5.
27 George JN, Sadler JE, Lämmle B. Platelets: Thrombotic thrombocytopenic purpura. Hematology 2002; 315-34.
28 George JN. Platelets. Lancet 2000; 355: 1531-9.
29 Gerhardt A, Scharf RE, Beckmann MW. et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000; 342: 374-80.
30 Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001; 119: 122-131
31 Ginsberg JS, Wells PS, Brill-Edwards P. Antiphospholipid antibodies and venous thromboembolism. Blood 1995; 86: 3685-91.
32 Girling J. Thromboembolism and thrombophilia. Current Obstet Gynaecol 2001; 11: 15-22.
33 Grady D, Wenger NK, Herrington D. et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. Ann Intern Med 2000; 132: 689-96.
34 Greer IA, Thromson AJ. Management of venous thromboembolism in pregnancy. Best Practice & Res Clin Obstet Gynaecol 2001; 15: 583-603.
35 Heilmann L, Rath W, von Tempelhoff GF. et al. Niedermolekulare Heparine in der Schwangerschaft. Deutsches Ärzteblatt 2002; 99: 2-9.
36 Heilmann L, Rath W. Thrombophilie in der Schwangerschaft. Unimed Bremen; 2002
37 Heilmann L. Die Anwendung der niedermolekularen Heparine in der Frauenheilkunde. Hämostaseologie 2001; 21: 130-42.
38 Janes LS, Goodall AH. Flow cytometric detection of circulating activated platelets and platelet hyperresponsiveness in pre-eclampsia and pregnancy. Clin Sci 1994; 86: 731-9.
39 Janes LS, Kyle PM, Redman C. et al. Flow cytometric detection of activated platelets in pregnant women prior to the development of preeclampsia. Thromb Haemost 1995; 74: 1059-63.
40 Kadir RA. Women and inherited bleeding disorders: Pregnancy and delivery. Sem Hematol 1999; 36: 28-35.
41 Kaushansky K. The vWF-Cleaving protease: new opportunities in TTP. Blood 2001; 98: 1643-4.
42 Kottke-Marchant K, Corcoran G. The laboratory diagnosis of platelet disorders. Arch Pathol Lab Med 2002; 126: 133-46.
43 Kovacevich GJ, Gaich SA, Lavin JP. et al. The prevalence of thromboembolic events among women with extended bed rest prescribed as part of the treatment for premature labor or preterm premature rupture of membranes. Am J Obstet Gynecol 2000; 182: 1089-92.
44 Kühne T. Hämorrhagische Diathese bei Störungen der primären Hämostase. Hämostaseologie 2000; 20: 48-52.
45 Lee CA. Women and inherited bleeding disorders: Menstrual issues. Sem Hematology 1999; 36: 2721-46.
46 Letsky EA, Greaves M. Guidelines an the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia. Brit J Haematol 1996; 95: 21-6.
47 Lindhoff-Last E, Bauersachs R. Heparin-induced thrombocytopeniaalternative anticoagulation in pregnancy and lactation. Sem Thromb Hemost 2002; 28: 439-45.
48 Lusher JM. Systemic causes of excessive uterine bleeding. Sem Hematology 1999; 36: 10-20.
49 Maconi M, Casolari B, Collell M. et al. Reference range of platelet count in normal pregnancy using Sysmex SE-9500. Sysmex J Int 2002; 12: 30-3.
50 Mannucci PM. How I treat patients with von Willebrand disease. Blood 2001; 97: 1915-9.
51 Martin JN, Perry KG, Blake PG. et al. Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome. Am J Obstet Gynecol 1997; 177: 1011-7.
52 McCreae KR, Bussel JB, Mannucci PM. et al. Platelets: An update an diagnosis and management of thrombocytopenic disorders. Hematology 2001; 282-305.
53 Obeidat B, MacDougall J, Harding K. Plasma exchange in a women with thrombotic thrombocytopenic purpura or severe pre-eclampsia. Brit J Obstet Gynaecol 2002; 109: 961-2.
54 Orte TL. Heparin-induced thrombocytopenia – state of the art. Sem Hematol 1998; 35: 3-36.
55 Paidas MJ, Haut MJ, Lockwood CJ. Platelet disorders in pregnancy: Implications for mother and fetus. Mount Sinai J Med 1994; 61: 389-403.
56 Peleg D, Hunter SK. Perinatal management of women with immune thrombocytopenic purpura: Survey of United States Perinatologists. Am J Obstet Gynecol 1999; 180: 645-50.
57 Ragni MV, Bontempo FA, Hassett AC. Von Willebrand disease and bleeding in women. Haemophilia 1999; 5: 313-7.
58 Ray JG, Chan WS. Deep vein thrombosis during pregnancy and the puerperium: A meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Survey 1999; 54: 265-71.
59 Rymer J, Wilson R, Ballard K. Making decisions about hormone replacement therapy. Br Med J 2003; 326: 322-6.
60 Stasi R, Stipa E, Oliva F. Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood 1994; 84: 4203-7.
61 Sullivan MHF, Clark NAC, de Swiet M. et al. Titration of antiplatelet treatment in pregnant women at risk of preeclampsia. Thromb Haemost 1998; 79: 743-50.
62 Thrombocytopenia in pregnancy. ACOG Practice Bulletin. 6. 1999
63 Thromboembolism in pregnancy. ACOG Practice Bulletin. 19. 2000
64 Veyradier A, Obert B, Houllier A. et al. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood 2001; 98: 1765-72.
65 Vianna JL, Khamashta MA, Ordi-Ros J. et al. Comparison of the primary and secondary antiphospholipid syndrome:A European multicenter study of 114 patients. Am J Med 1994; 96: 3-9.
66 Wilson WA, Gharafi AE, Koike T. et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthr Rheumat 1999; 42: 1309-11.
67 Witlin AG, Sibai BM. Diagnosis and management of women with hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome. Hospital Physician 1999; 49: 40-5.